Urinary metabonomic study on colorectal cancer

Journal of Proteome Research

Volumn 9, Issue 3, 2010, Pages 1627-1634

  Qiu, Yunping ^a   Cai, Guoxiang ^b   Su, Mingming ^c   Chen, Tianlu ^d   Liu, Yumin ^d   Xu, Ye ^b   Ni, Yan ^d   Zhao, Aihua ^d   Cai, Sanjun ^b   Xu, Lisa X ^d   Jia, Wei ^a,d  

^a UNIVERSITY OF NORTH CAROLINA AT GREENSBORO   (United States)

^b FUDAN UNIVERSITY   (China)

^c David H Murdock Research Institute   (United States)

^d Shanghai Jiao Tong University   (China)

Author keywords

Colorectal cancer; Gas chromatography mass spectrum; Metabolite profile; Metabolomics; Metabonomics; Urine

Indexed keywords

5 HYDROXYTRYPTOPHAN; GLUTAMIC ACID; HISTAMINE; TRYPTOPHAN;

ADULT; AGED; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOMICS; CANCER PATIENT; CITRIC ACID CYCLE; COLORECTAL CANCER; CONTROLLED STUDY; DOWN REGULATION; FEMALE; HUMAN; INTESTINE FLORA; MAJOR CLINICAL STUDY; MALE; MASS FRAGMENTOGRAPHY; METABOLITE; METABONOMICS; NONHUMAN; POSTOPERATIVE PERIOD; PRECANCER; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RAT; URINALYSIS;

1,2-DIMETHYLHYDRAZINE; ADULT; AGED; ANIMALS; CASE-CONTROL STUDIES; COLORECTAL NEOPLASMS; DISCRIMINANT ANALYSIS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LEAST-SQUARES ANALYSIS; MALE; METABOLOME; METABOLOMICS; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; PRINCIPAL COMPONENT ANALYSIS; PROTEINURIA; RATS; RATS, SPRAGUE-DAWLEY; RATS, WISTAR;

RATTUS;

EID: 77949822339     PISSN: 15353893     EISSN: 15353907     Source Type: Journal    
DOI: 10.1021/pr901081y     Document Type: Article

References (39)

1. Jemal, A.; Siegel, R.; Ward, E.; Hao, Y.; Xu, J.; Murray, T.; Thun, M. J. Cancer statistics, 2008. CA Cancer J. Clin. 2008, 58 (2), 71-96.
2. Sung, J. J.; Lau, J. Y.; Goh, K. L.; Leung, W. K. Increasing incidence of colorectal cancer in Asia: implications for screening. Lancet Oncol. 2005, 6 (11), 871-876
3. Winawer, S. J.; Zauber, A. G.; May Nah, H.; O'Brien, M. J.; Gottlieb, L. S.; Sternberg, S. S.; Waye, J. D.; Schapiro, M.; Bond, J. H.; Panish, J. F.; Ackroyd, F.; Shike, M.; Kurtz, R. C.; Homsby-Lewls, L.; Gerdes, H.; Stewart, E. T.; Lightdale, C. J.; Edelman, M.; Fleisher, M. Prevention of colorectal cancer by colonoscopic polypectomy. N. Eng. J. Med. 1993, 329 (27), 1977-1981
4. Fletcher, R. H. Carcinoembryonic antigen, Ann. Intern, Med. 1988, 104 (1), 66-73.
5. Kronborg, O.; Fenger, C.; Olsen, J.; Jörgensen, O. D.; Söndergaard, O. Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet 1996, 348 (9040), 1467-1471
6. Mandel, J. S.; Bond, J. H.; Church, T. R.; Snover, D. C.; Bradley, G. M.; Schuman, L. M.; Ederer, F. Reducing mortality from colorectal cancer by screening for fecal occult blood. N. Engl. J. Med. 1993, 328 (19), 1365-1371
7. Tiziani, S.; Lopes, V.; Gunther, U. L. Early stage diagnosis of oral cancer using 1H NMR-based metabolomics. Neoplasia 2009, 11 (3), 269-276
8. Kim, K.; Aronov, P.; Zakharkin, S. O.; Anderson, D.; Perroud, B.; Thompson, I. M.; Weiss, R. H. Urine metabolomics analysis for kidney cancer detection and biomarker discovery. Mol. Cell. Proteomics 2009, 8(3), 558-570
9. Denkert, C.; Budczies, J.; Kind, T.; Weichen, W.; Tablack, P.; Sehouli, J.; Niesporek, S.; Konsgen, D.; Dietel, M.; Fiehn, O. Mass spectrometry-based metabolic profiling reveals different metabolite patterns in invasive ovarian carcinomas and ovarian borderline tumors. Cancer Res. 2006, 66 (22), 10795-10804
10. Chan, E. C.; Koh, P. K.; Mal, M.; Cheah, P. Y.; Eu, K. W.; Backshall, A.; Cavill, R.; Nicholson, J. K.; Keun, H. C. Metabolic profiling of human colorectal cancer using high-resolution magic angle spinning nuclear magnetic resonance (HR-MAS NMR) spectroscopy and gas chromatography mass spectrometry (GC/MS). J. Proteome Res. 2009, 8 (1), 352-361
11. Denkert, C.; Budczies, J.; Weichen, W.; Wohlgemuth, G.; Scholz, M.; Kind, T.; Niesporek, S.; Noske, A.; Buckendahl, A.; Dietel, M.; Fiehn, O. Metabolite profiling of human colon carcinomaderegulation of TCA cycle and amino acid, turnover. Mol. Cancer 2008, 7, 72.
12. Piotto, M. M. F. M.; Dillmann, B.; Imperiale, A.; Neuville, A.; Brigand, C.; Bellocq, J.-P.; Elbayed, K.; Namer, I. J. Metabolic characterization of primary human colorectal cancers using high resolution magic angle spinning 1H magnetic resonance spectroscopy. Metabolomics 2008, 5 (3), 292-301.
13. Qiu, Y.; Cai, G.; Su, M.; Chen, T.; Zheng, X.; Xu, Y.; Ni, Y.; Zhao, A., Xu, L. X.; Cal, S.; Jia, W. Serum metabolite profiling of human colorectal cancer using GC-TOFMS and UPLC-QTOFMS. J. Proteome Res. 2009, 8 (10), 4844-4850
14. Qiu, Y.; Su, M.; Liu, Y.; Chen, M.; Gu, J.; Zhang, J.; Jia, W. Application of ethyl chloroformate derealization for gas chromatography-mass spectrometry based metabonomic profiling. Anal Chim. Acta 2007, 583 (2), 277-283
15. Smith, C. A.; Want, E. J.; O'Maille, G.; Abagyan, R.; Siuzdak, G. XCMS: processing mass spectrometry data for metabolite profiling using nonlinear peak alignment, matching, and identification. Anal. Chem. 2006, 78 (3), 779-787
16. Williamson, D. H.; Farrell, R.; Kerr, A.; Smith, R. Urine 3-methyl histidine in man as a measure of muscle protein catabolism after injury. Clin. Sci. Mol. Med. 1977, 52 (2), P17-P18.
17. Newell, L. E.; Meddle, J. A. The potent colon carcinogen, 1,2dimethylhydrazine induces mutations primarily in the colon. Mutat. 2004, 564 (1), 1-7.
18. Bird, R. P. Role of aberrant crypt foci in understanding the pathogenesis of colon cancer. Cancer Lett. 1995, 93 (1), 55-71.
19. Bird, R. P. Observation and quantification of aberrant crypts in the murine colon, treated with a colon, carcinogen: preliminary findings. Cancer Lett. 1987, 37(2), 147-151
20. Agner, A. R.; Bazo, A. P.; Ribeiro, L. R.; Salvadoři, D. M. DNA damage and aberrant crypt foci as putative biomarkers to evaluate the chemopreventive effect of annatto (Bixa orellana L.) in rat colon carcinogenesis. Mutat. Res. 2005, 582 (1-2), 146-154
21. Halabe Bucay, A The biological significance of cancer: mitochondria as a cause of cancer and the inhibition of glycolysis with citrate as a cancer treatment. Med. Hypotheses 2007, 69 (4), 826-828
22. Bi, X.; Lin, Q.; Foo, T. W.; Joshi, S.; You, T.; Shen, H. M.; Ong, C. N.; Cheah, P. Y.; Eu, K. W.; Hew, C. L. Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis. Mol. Cell. Proteomics 2006, 5 (6), 1119-1130
23. Punch, D. P. Predictors and consequences of symptom reporting behaviors in colorectal-cancer patients. Med. Care 1988, 26 (10), 1000-1008
24. Xu, W.; Tamim, H.; Shapiro, S.; Stang, M. R.; Collet, J. P. Use of antidepressants and risk of colorectal, cancer: a nested, case-control study, Lancet Oncol. 2006, 7 (4), 301-308
25. Tutton, P. J.; Barkla, D. H. Influence of inhibitors of serotonin uptake on intestinal epithelium and colorectal carcinomas. Br. J. Cancer 1982, 46 (2), 260-265
26. Granerus, G.; Anlman, H. Histamine metabolism in patients with foregut carcinoid, tumours. Agents Actions 1993, 38 (Special Issue II).
27. Rechner, A. R.; Smith, M. A.; Kuhnle, G.; Gibson, G. R.; Debnam, E. S.; Srai, S. K.; Moore, K. P.; Rice-Evans, C. A. Colonic metabolism of dietary polyphenols: influence of structure on microbial fermentation products. Free Radie. Biol. Med. 2004, 36 (2), 212-225
28. Stella, C.; Beckwith-Hall, B.; Cloarec, O.; Holmes, E.; Lindon, J. C.; Powell, J.; van der Ouderaa, F.; Bingham, S.; Cross, A. J.; Nicholson, J. K. Susceptibility of Human Metabolic Phenotypes to Dietary Modulation. T. Proteome Res. 2006, 5 (10), 2780-2788
29. Selmer, T.; Andrei, P. I. p-Hydroxyphenylacetate decarboxylase from Clostridium difficile. A novel glycyl radical enzyme catalysing the formation of p-cresol. Eur. J. Biochem. 2001, 268 (5), 1363-1372
30. Stella, C.; Beckwith-Hall, B.; Cloarec, O.; Holmes, E.; Lindon, J. C.; Powell, J.; van der Ouderaa, F.; Bingham, S.; Cross, A. J.; Nicholson, J. K. Susceptibility of human metabolic phenotypes to dietary modulation. J. Proteome Res. 2006, 5 (10), 2780-2788
31. Elsden, S. R.; Hilton, M. G.; Waller, J. M. End products of metabolism of aromatic amino-adds by clostridia. Arch, Microbiol. 1976, 107(3), 283Z-8.
32. Scanlan, P. D.; Shanahan, F.; Clune, Y.; Collins, J. K.; O'Sulllvan, G. C.; O'Riordan, M.; Holmes, E.; Wang, Y.; Marchesi, J. R. Cultureindependent analysis of the gut microbiota in colorectal cancer and polyposis. Environ. Microbiol. 2008, 10 (5), 1382.
33. Wollowski, I.; Rechkemmer, G.; Pool-Zobel, B. L. Protective role of probiotics and prebiotics in colon cancer. Am. J. Clin. Nutr. 2001, 73 (2), 451S-5S.
34. Garcia-Caballero, M.; Neugebauer, E.; Campos, R.; Nunez de Castro, I.; Vara-Thorbeck, C. Increased hlstidine decarboxylase (HDC) activity in human colorectal cancer: results of a study on. ten patients. Agents Actions 1988, 23 (3-4), 357-360
35. Meister, A.; Anderson, M. E. GLUTATHIONE. Annu. Rev. Biochem. 1983, 52, 711-760
36. Balendlran, G. K.; Dabur, R.; Fraser, D. The role of glutathione in cancer. Cell Biochem. Funct. 2004, 22 (6), 343-352
37. Howie, A. F.; Forrester, L. M.; Glancey, M. J.; Schlager, J. J.; Powis, G.; Beckett, G. J.; Hayes, J. D.; Wolf, C. R. Glutathione S-transferase and glutathione-peroxidase expression in normal and tumor human, tissues. Carcinogenesis 1990, 11 (3), 451-458
38. Adler, V.; Yin, Z. M.; Fuchs, S. Y.; Benezra, M.; Rosario, L.; Tew, K. D.; Pincus, M. R.; Sardana, M.; Henderson, C. J.; Wolf, C. R.; Davis, R. J.; Ronai, Z. Regulation of JNK signaling by GSTp. Embo J. 1999, 18 (5), 1321-1334
39. Parker, M. T.; Gemer, E. W. Polyamine-mediated post-transcriptional regulation of COX-2. Biochimie 2002, 84 (8), 815-819